| Autor: |
Bingda Piao, Tong Li, Hongliang Zhong, Hongchao Yang, Yang Wang, He Liu |
| Jazyk: |
angličtina |
| Rok vydání: |
2023 |
| Předmět: |
|
| Zdroj: |
Heliyon, Vol 9, Iss 4, Pp e14504- (2023) |
| Druh dokumentu: |
article |
| ISSN: |
2405-8440 |
| DOI: |
10.1016/j.heliyon.2023.e14504 |
| Popis: |
Objectives: Glycoprotein (GP) IIb/IIIa receptor antagonists (Tirofiban) are often used as antiplatelet agents in patients undergoing interventional therapy due to acute coronary syndrome and cerebrovascular diseases. Thrombocytopenia is a common complication of GP IIb/IIIa receptor antagonist, with an incidence of 1%–5%, whereas acute profound thrombocytopenia (platelet count |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
